Total consolidated revenue increased by 11.5% to $2.04 billion in 2025 from $1.83 billion in 2024. The Imaging Center segment revenue grew by 10.9% to $1.99 billion, driven by higher fees and increased procedure volumes, especially advanced imaging like PET/CT. The Digital Health segment revenue surged by 41.1% to $92.7 million, with AI-related revenue up 64.9% and Enterprise Imaging revenue up 29.0%. A net loss attributable to common stockholders of $18.65 million was reported in 2025, compared to a net income of $2.79 million in 2024. Adjusted EBITDA increased to $300.2 million in 2025 from $279.5 million in 2024. The company acquired 11 imaging centers in 2025, contributing to a total of 418 centers operated or managed. Three significant Digital Health acquisitions were completed in 2025: See-Mode Technologies ($28.9 million), iCAD, Inc. ($110.7 million all-stock), and CIMAR UK Limited ($37.0 million). Executive compensation for several key personnel (Mark D. Stolper, Stephen M. Forthuber, Norman R. Hames, Mital Patel, David J. Katz, Gregory Sorensen, Cornelis Wesdorp) increased effective January 1, 2026. Lease abandonment charges increased significantly to $8.6 million in 2025 from $2.5 million in 2024 due to closing seven low-utilization imaging centers. Total operating expenses increased by 14.7% to $1.98 billion, outpacing revenue growth, primarily due to higher procedure volumes, staffing costs, wage inflation, and acquisition-related expenses. Interest expense decreased by 12.4% to $69.9 million due to a repricing of the Barclays Revolving Credit Facility in Q4 2024, partially offset by $100 million incremental term loan borrowings in Q2 2025.